"A new consumer-friendly form ( is now available for making reports to MedWatch, the Food and Drug Administration's (FDA) on-line system for collecting information about serious problems with drugs, medical devices and other FDA-"...
Side effects associated with Brevital Sodium (methohexital sodium for injection) are extensions of pharmacologic effects and include:
Drug Abuse And Dependence
Controlled Substance-Brevital Sodium (methohexital sodium for injection) is a Schedule IV drug.
Brevital Sodium (methohexital sodium for injection) may be habit-forming.
Read the Brevital Sodium (methohexital sodium for injection) Side Effects Center for a complete guide to possible side effects »
Prior chronic administration of barbiturates or phenytoin (e. g. for seizure disorder) appears to reduce the effectiveness of Brevital Sodium (methohexital sodium for injection) . Barbiturates may influence the metabolism of other concomitantly used drugs, such as phentyoin, halothane, anticoagulants, corticosteroids, ethyl alcohol, and propylene glycol-containing solutions.
Last reviewed on RxList: 6/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Brevital Sodium Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.